This is the authors' abstract. We don't add key points for this paper.
Traditional antibiotics are often restricted by resistance, adverse effects, and diminishing potency. Hybrid drug design, which combines two pharmacophores in a single molecule, offers a new alternative. Chalcones, flavonoid derivatives possessing α, β- unsaturated carbonyl system, exhibit antibacterial, anti-inflammatory, and antidiabetic properties. The Claisen-Schmidt condensation is used to synthesize the chalcones, which are then conjugated with aspirin fragments by esterification or amidat
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kishor et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: